Compare ZURA & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | LPAA |
|---|---|---|
| Founded | 2022 | 2024 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 521.8M | 299.3M |
| IPO Year | N/A | N/A |
| Metric | ZURA | LPAA |
|---|---|---|
| Price | $6.10 | $10.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.78 | N/A |
| AVG Volume (30 Days) | ★ 552.4K | 2.3K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $31.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $10.21 |
| 52 Week High | $7.25 | $10.74 |
| Indicator | ZURA | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 60.64 |
| Support Level | $5.49 | $10.40 |
| Resistance Level | $6.99 | $10.74 |
| Average True Range (ATR) | 0.49 | 0.01 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 60.14 | 88.89 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Launch One Acquisition Corp is a blank check company.